Suchergebnisse - "Cosgrove, Catherine A"

PubPharm (33)

1

Propositive follow-up : Long-term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV

enthalten in: HIV medicine | 2024

von San Francisco Ramos, A. | Isitt, C. | Athaide, S. | +8

2

The predictive role of symptoms in COVID-19 diagnostic models : A longitudinal insight

enthalten in: Epidemiology and infection | 2024

von Bird, O. | Galiza, E. | Baxter, D. | +35

3

Propositive follow‐up : Long‐term immune responses to the4CMenB and MenACWY vaccines in people living with HIV

enthalten in: HIV Medicine | 2024

von San Francisco Ramos, A. | Isitt, C. | Athaide, S. | +8

4

Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK : a randomised, observer-blind, active-controlled trial

enthalten in: The Lancet. Infectious diseases | 2023

von Lee, I. | Cosgrove, C. | Moore, P. | +64

CommentIn: Lancet Infect Dis. 2023 Sep;23(9):984-985. - PMID 37348518

5

The propositive study : Immunogenicity and safety of a four-component recombinant protein-based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIV

enthalten in: HIV medicine | 2023

von Isitt, C. | Bartolf, A. | Andrews, N. | +7

6

A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273

enthalten in: bioRxiv.org | 2023

von Lee, I. | Cosgrove, C. | Moore, P. | +32

7

COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2

enthalten in: EClinicalMedicine | 2023

von Szubert, A. | Pollock, K. | Cheeseman, H. | +28

8

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Heath, P. | Galiza, E. | Baxter, D. | +42

9

The propositive study : Immunogenicity and safety of a four‐component recombinant protein‐based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIV

enthalten in: HIV Medicine | 2023

von Isitt, C. | Bartolf, A. | Andrews, N. | +7

10

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19 : COVAC1, a phase I, dose-ranging trial

enthalten in: EClinicalMedicine | 2022

von Pollock, K. | Cheeseman, H. | Szubert, A. | +78